Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Agxt2em1/Cya
Common Name:
Agxt2-KO
Product ID:
S-KO-17231
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Agxt2-KO
Strain ID
KOCMP-268782-Agxt2-B6J-VB
Gene Name
Agxt2
Product ID
S-KO-17231
Gene Alias
-
Background
C57BL/6JCya
NCBI ID
268782
Modification
Conventional knockout
Chromosome
15
Phenotype
MGI:2146052
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Agxt2em1/Cya mice (Catalog S-KO-17231) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000022858
NCBI RefSeq
NM_001031851
Target Region
Exon 4
Size of Effective Region
~2.5 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Agxt2, or alanine-glyoxylate aminotransferase 2, is a multifunctional mitochondrial aminotransferase. It was first identified in 1978. Although initially overlooked due to its lower activity in glyoxylate metabolism compared to AGXT1, it has now been "rediscovered" to have multiple substrates and products. It is involved in key mitochondrial pathways and is potentially important for various physiological functions [1].

Agxt2 has been associated with multiple diseases. Its deficiency in expression or activity may play a role in the progression of cardiovascular or renal diseases through affecting the metabolism of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) [2]. In hepatocellular carcinoma, lower Agxt2 levels are associated with a worse prognosis, and its activation can decrease cholesterol levels in cancer cells, suppressing their growth and metastasis [3]. A SNP (rs37369) in Agxt2 is a risk factor for diabetes mellitus [4]. In cats, genetic variants of Agxt2 are associated with different risks of calcium oxalate stone formation [5]. Also, Agxt2 is identified as a biomarker of acute kidney injury, and its down-regulation may induce AKI [6]. The rs37369 polymorphism of Agxt2 can affect the renal function in chronic heart failure patients, especially in smokers [7]. Missense variants of Agxt2 may be related to vascular diseases like hypertension and diabetes mellitus via the nitric oxide system [8]. Another SNP (rs180749) is associated with depressive symptoms [9]. In Egyptians, genetic variants of Agxt2 are correlated with serum ADMA and SDMA levels and the incidence of coronary artery disease [10].

In conclusion, Agxt2 is a multifunctional mitochondrial aminotransferase involved in various biological processes. Studies, including those on genetic variants, have revealed its significance in multiple disease areas such as cardiovascular, renal, hepatic, metabolic, and neurological diseases. Understanding Agxt2's functions through these genetic-based studies provides insights into disease mechanisms and potential therapeutic targets.

References:

1. Rodionov, Roman N, Jarzebska, Natalia, Weiss, Norbert, Lentz, Steven R. 2014. AGXT2: a promiscuous aminotransferase. In Trends in pharmacological sciences, 35, 575-82. doi:10.1016/j.tips.2014.09.005. https://pubmed.ncbi.nlm.nih.gov/25294000/

2. Hu, Xiao-Lei, Li, Mu-Peng, Song, Pei-Yuan, Tang, Jie, Chen, Xiao-Ping. 2017. AGXT2: An unnegligible aminotransferase in cardiovascular and urinary systems. In Journal of molecular and cellular cardiology, 113, 33-38. doi:10.1016/j.yjmcc.2017.09.010. https://pubmed.ncbi.nlm.nih.gov/28970090/

3. Chen, Tian, Xiang, Lunjian, Zhang, Wenjin, Xia, Zhenyi, Chen, Weixian. 2024. AGXT2 Suppresses the Proliferation and Dissemination of Hepatocellular Carcinoma Cells by Modulating Intracellular Lipid Metabolism. In Journal of hepatocellular carcinoma, 11, 1623-1639. doi:10.2147/JHC.S470250. https://pubmed.ncbi.nlm.nih.gov/39206420/

4. Kumon, Hiroshi, Miyake, Yoshihiro, Yoshino, Yuta, Kawamoto, Ryuichi, Ueno, Shu-Ichi. 2022. Functional AGXT2 SNP rs37369 Variant Is a Risk Factor for Diabetes Mellitus: Baseline Data From the Aidai Cohort Study in Japan. In Canadian journal of diabetes, 46, 829-834. doi:10.1016/j.jcjd.2022.06.004. https://pubmed.ncbi.nlm.nih.gov/35961823/

5. Hall, Jean A, Panickar, Kiran S, Brockman, Jeffrey A, Jewell, Dennis E. 2022. Cats with Genetic Variants of AGXT2 Respond Differently to a Dietary Intervention Known to Reduce the Risk of Calcium Oxalate Stone Formation. In Genes, 13, . doi:10.3390/genes13050791. https://pubmed.ncbi.nlm.nih.gov/35627178/

6. Wei, Jinshuang, Zhang, Junlin, Wei, Junyu, Lei, Fengying, Qin, Yuanhan. 2023. Identification of AGXT2, SHMT1, and ACO2 as important biomarkers of acute kidney injury by WGCNA. In PloS one, 18, e0281439. doi:10.1371/journal.pone.0281439. https://pubmed.ncbi.nlm.nih.gov/36735737/

7. Hu, Xiao-Lei, Zeng, Wen-Jing, Li, Mu-Peng, Zhang, Ke, Chen, Xiao-Ping. 2017. AGXT2 rs37369 polymorphism predicts the renal function in patients with chronic heart failure. In Gene, 637, 145-151. doi:10.1016/j.gene.2017.09.038. https://pubmed.ncbi.nlm.nih.gov/28942034/

8. Yoshino, Yuta, Kumon, Hiroshi, Mori, Takaaki, Iga, Jun-Ichi, Ueno, Shu-Ichi. 2021. Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey method. In BMC genomics, 22, 287. doi:10.1186/s12864-021-07612-3. https://pubmed.ncbi.nlm.nih.gov/33879046/

9. Kumon, Hiroshi, Miyake, Yoshihiro, Yoshino, Yuta, Kawamoto, Ryuichi, Ueno, Shu-Ichi. 2024. Functional AGXT2 SNP rs180749 variant and depressive symptoms: Baseline data from the Aidai Cohort Study in Japan. In Journal of neural transmission (Vienna, Austria : 1996), 131, 267-274. doi:10.1007/s00702-024-02742-w. https://pubmed.ncbi.nlm.nih.gov/38261033/

10. Amir, Mina, Hassanein, Sally I, Abdel Rahman, Mohamed F, Gad, Mohamed Z. 2018. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians. In Molecular biology reports, 45, 2411-2419. doi:10.1007/s11033-018-4407-1. https://pubmed.ncbi.nlm.nih.gov/30284143/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest